Sleepres, Inc.

Sleepres, Inc. specializes in reusable inspiratory and expiratory limb respiratory tubing. These devices are designed specifically for use in positive airway pressure (PAP) therapy systems, such as the V-Com and SleepRes PAP System, which provide respiratory support during sleep. The tubing connects to the patient interface and the PAP device, ensuring proper airflow for effective therapy.

Sleepres, Inc. is based in the United States. As a U.S.-based manufacturer, its devices are subject to FDA regulations. The company’s products are classified under FDA categories, with some falling under Class I (generally low-risk devices) and others under Class II (devices requiring special controls to ensure safety and effectiveness). This classification determines the regulatory pathway, such as the 510(k) premarket notification process or UDI requirements, ensuring compliance with U.S. medical device standards.

Sleepres, Inc.’s devices are listed in the FDA’s 510(k) registry, which documents premarket notifications for devices deemed substantially equivalent to legally marketed predicates. Additionally, the company’s products are included in the FDA’s Unique Device Identifier (UDI) system, a standardized system for tracking medical devices throughout their lifecycle. These registries help ensure transparency and traceability of the devices in compliance with U.S. regulatory requirements.

Sleepres, Inc.’s devices are classified under two FDA categories: Class I and Class II. Class I devices, such as certain reusable respiratory tubing, are typically low-risk and subject to general controls like good manufacturing practices. Class II devices, which may include more complex tubing systems or those requiring performance standards, require additional regulatory oversight, such as special controls or postmarket surveillance. The classification ensures appropriate regulatory scrutiny based on the device’s risk level and intended use.